Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 13 studies | 38% ± 18% | |
astrocyte | 11 studies | 32% ± 16% | |
endothelial cell | 10 studies | 26% ± 11% | |
GABAergic neuron | 9 studies | 47% ± 22% | |
glutamatergic neuron | 9 studies | 41% ± 25% | |
pericyte | 7 studies | 27% ± 11% | |
smooth muscle cell | 7 studies | 26% ± 10% | |
interneuron | 6 studies | 48% ± 28% | |
fibroblast | 6 studies | 27% ± 8% | |
adipocyte | 5 studies | 20% ± 2% | |
neuron | 4 studies | 26% ± 10% | |
epithelial cell | 4 studies | 31% ± 14% | |
cardiac muscle cell | 4 studies | 23% ± 1% | |
Mueller cell | 4 studies | 27% ± 10% | |
GABAergic interneuron | 3 studies | 34% ± 1% | |
granule cell | 3 studies | 19% ± 3% | |
endothelial cell of lymphatic vessel | 3 studies | 16% ± 1% | |
type I pneumocyte | 3 studies | 20% ± 4% | |
oligodendrocyte | 3 studies | 33% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 601.91 | 2632 / 2642 | 99% | 25.76 | 699 / 705 |
prostate | 100% | 938.85 | 244 / 245 | 97% | 7.13 | 485 / 502 |
thymus | 100% | 1360.90 | 653 / 653 | 90% | 11.81 | 547 / 605 |
kidney | 100% | 708.33 | 89 / 89 | 88% | 8.99 | 789 / 901 |
adrenal gland | 98% | 438.59 | 253 / 258 | 83% | 9.25 | 190 / 230 |
breast | 100% | 596.79 | 459 / 459 | 69% | 3.53 | 769 / 1118 |
pancreas | 95% | 252.88 | 311 / 328 | 67% | 3.25 | 120 / 178 |
lung | 99% | 519.68 | 574 / 578 | 48% | 2.30 | 559 / 1155 |
ovary | 100% | 786.69 | 180 / 180 | 44% | 1.90 | 188 / 430 |
liver | 98% | 299.56 | 222 / 226 | 36% | 1.29 | 147 / 406 |
esophagus | 95% | 528.45 | 1374 / 1445 | 24% | 1.00 | 44 / 183 |
stomach | 96% | 362.60 | 344 / 359 | 23% | 1.02 | 65 / 286 |
bladder | 100% | 711.19 | 21 / 21 | 18% | 0.76 | 93 / 504 |
uterus | 99% | 869.63 | 169 / 170 | 18% | 0.95 | 83 / 459 |
skin | 82% | 376.25 | 1482 / 1809 | 24% | 1.09 | 115 / 472 |
adipose | 100% | 614.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1900.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
intestine | 82% | 501.20 | 794 / 966 | 13% | 0.54 | 70 / 527 |
heart | 95% | 503.51 | 816 / 861 | 0% | 0 | 0 / 0 |
spleen | 92% | 284.28 | 221 / 241 | 0% | 0 | 0 / 0 |
muscle | 80% | 176.69 | 642 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.11 | 22 / 80 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.82 | 6 / 29 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.32 | 4 / 45 |
peripheral blood | 5% | 27.45 | 46 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0042428 | Biological process | serotonin metabolic process |
GO_0042415 | Biological process | norepinephrine metabolic process |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0030534 | Biological process | adult behavior |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RNF180 |
Protein name | Ring finger protein 180 E3 ubiquitin-protein ligase RNF180 (EC 2.3.2.27) (RING finger protein 180) (RING-type E3 ubiquitin transferase RNF180) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase which promotes polyubiquitination and degradation by the proteasome pathway of ZIC2. . |
Accessions | Q86T96 D6RE88 ENST00000389100.9 [Q86T96-1] ENST00000296615.10 [Q86T96-2] ENST00000504296.1 |